NOVAREX Co., Ltd.
KKRX:1947009,560.00
KRW
-190.00
(-1.95%)
ISIN
KR7194700001
Return %
Stock
S&P 500
1Y
-46.32
13.14
3Y
-6.64
80.78
5Y
-52.36
67.74
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- Full Time Employees
- 505
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- Cheongju-si South Korea
- IPO Date
- Nov 14, 2018
- Website
- novarex.co.kr
- Similar Companies
- Business
- NOVAREX Co., Ltd. is a South Korea-based original equipment manufacturer and original design manufacturer specializing in the research, development, and production of health functional foods and dietary supplements. Founded in 1995 and headquartered in Cheongju-si, Chungcheongbuk-do, South Korea, the company operates dedicated manufacturing facilities and a Life Science Research Center, holding one of the industry's largest domestic portfolios of individually recognized functional ingredients certified by South Korea's Ministry of Food and Drug Safety. NOVAREX Co., Ltd. provides full-lifecycle OEM and ODM solutions spanning raw ingredient sourcing, clinical efficacy testing, product formulation, regulatory approval, mass manufacturing, and customized packaging. The company's comprehensive product and service portfolio encompasses vitamin and mineral supplements; probiotics, prebiotics, and gastrointestinal health formulas; eye health supplements including lutein and astaxanthin formulations; joint and bone support products containing MSM, glucosamine, and calcium complexes; inner-beauty functional foods comprising marine collagen and hyaluronic acid; metabolic and weight management formulations; liver health and fatigue-recovery preparations utilizing milk thistle extracts; immune support formulas; and diversified delivery dosage formats, including hard and soft gelatin capsules; compressed tablets; ultra-compact micro-tablets; water-soluble powders and granules; functional chewable gummies; stick jellies; liquid ampoules; and integrated dual-formulation multi-packs. The company serves pharmaceutical firms, consumer health brands, multi-level marketing distributors, and global nutrition enterprises across South Korea, Mainland China, Southeast Asia, North America, and Europe, maintaining strategic manufacturing agreements with major international nutritional brands such as GNC and Blackmores. In recent developments, NOVAREX Co., Ltd. has accelerated its international expansion, driven by significant export revenue growth across Asian markets, particularly in China and Southeast Asia. To support surging overseas OEM and ODM demand, the company has expanded its manufacturing footprint with additional capacity additions at its Osong facility cluster, advanced the commercial rollout of proprietary manufacturing technologies such as its MiLi ultra-small tablet and specialized dual-cap packaging formats, and increased its presence across regional health and nutrition trade platforms to broaden its global client network.